Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
27%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
IXJ
114
HOLDINGS
11%
ALSO IN CANC
CANC
56
HOLDINGS
21%
ALSO IN IXJ
SECTOR DRIFT (IXJ minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IXJ |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.4% | 4.5% | 4.5% |
|
MERCK & CO. INC. | 3.7% | 3.9% | 3.7% |
 |
ASTRAZENECA PLC | 3.6% | 4.4% | 3.6% |
 |
NOVARTIS AG | 3.6% | 4.6% | 3.6% |
|
JOHNSON & JOHNSON | 7.1% | 2.5% | 2.5% |
IXJ Overweight Relative to CANC
|
ELI LILLY & CO | 5.9% |
|
JOHNSON & JOHNSON | 4.6% |
|
ROCHE HOLDING LTD | 4.0% |
|
UNITEDHEALTH GROUP INC | 3.1% |
|
THERMO FISHER SCIENTIFIC INC | 2.5% |
|
ABBVIE INC | 2.5% |
|
ABBOTT LABORATORIES | 2.4% |
|
INTUITIVE SURGICAL INC | 2.1% |
|
PFIZER INC | 1.9% |
 |
NOVO NORDISK A/S-B | 1.8% |
IXJ Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -6.2% |
|
BRIDGEBIO PHARMA, INC. | -4.5% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.1% |
|
GENMAB A/S SPONSORED ADR | -3.4% |
|
NUVALENT, INC. CLASS A | -3.3% |
|
COGENT BIOSCIENCES INC | -3.2% |
|
IMMUNOME, INC. | -2.9% |
|
BRISTOL-MYERS SQUIBB CO | -2.8% |
|
CELCUITY INC. | -2.4% |
|
ARCELLX, INC. | -2.4% |